Literature DB >> 18699838

Acute generalized exanthematous pustulosis after pemetrexed, and recurrence after re-introduction.

A Bracke1, E Van Marck, J Lambert.   

Abstract

Acute generalized exanthematous pustulosis (AGEP) is a rare cutaneous reaction, which in most cases, is related to medication. Pemetrexed is an antifolate drug, approved for treatment of metastatic non-small-cell lung cancer (NSCLC) and malignant pleural mesothelioma (MPM). We present a case of AGEP caused by pemetrexed, and a recurrence of this eruption after re-introduction of pemetrexed despite use of corticosteroids.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18699838     DOI： 10.1111/j.1365-2230.2008.02902.x

Source DB:  PubMed          Journal:  Clin Exp Dermatol        ISSN： 0307-6938            Impact factor:   3.470


  3 in total

1.  Pemetrexed-induced radiation recall dermatitis in a patient with lung adenocarcinoma: case report and literature review.

Authors:  Jin Ge; Vivek Verma; Andrew Hollander; Corey Langer; Charles B Simone
Journal:  J Thorac Dis       Date:  2016-12       Impact factor: 2.895

2.  Revisiting cutaneous adverse reactions to pemetrexed.

Authors:  Claudine Piérard-Franchimont; Pascale Quatresooz; Marie-Annick Reginster; Gérald E Piérard
Journal:  Oncol Lett       Date:  2011-07-05       Impact factor: 2.967

3.  Toxic epidermal necrolysis related to AP (pemetrexed plus cisplatin) and gefitinib combination therapy in a patient with metastatic non-small cell lung cancer.

Authors:  Ji-Jie Huang; Shu-Xiang Ma; Xue Hou; Zhao Wang; Yin-Duo Zeng; Tao Qin; Xiao-Xiao Dinglin; Li-Kun Chen
Journal:  Chin J Cancer       Date:  2014-11-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.